Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The IMASH trial is a simple, randomized, double-blinded, placebo-controlled, multi-center
trial to answer the question: "Does intravenous magnesium sulfate improve clinical outcome
after aneurysmal subarachnoid hemorrhage?"